CAS: 154540-49-5 - 4-Amino-5-chloro-N-(1-((4-fluorophenyl)methyl)-4-piperidinyl)-2-methox ybenzamide
Formula:C20H23ClFN3O2
InChI:InChI=1/C20H23ClFN3O2/c1-27-19-11-18(23)17(21)10-16(19)20(26)24-15-6-8-25(9-7-15)12-13-2-4-14(22)5-3-13/h2-5,10-11,15H,6-9,12,23H2,1H3,(H,24,26)
- Synonyms:
- Fluoroclebopride
- 4-amino-5-chloro-N-[1-(4-fluorobenzyl)piperidin-4-yl]-2-methoxybenzamide
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Benzamide,4-amino-5-chloro-N-[1-[(4-fluorophenyl)methyl]-4-piperidinyl]-2-methoxy- REF: IN-DA007G2JCAS: 154540-49-5 | 98% | To inquire | Tue 21 Jan 25 | |
Fluoroclebopride REF: TM-T3187CAS: 154540-49-5 | 99.8% - 99.91% | 35.00 €~846.00 € | Mon 27 Jan 25 | |
4-Amino-5-Chloro-N-[1-[(4-Fluorophenyl)Methyl]Piperidin-4-Yl]-2-Methoxybenzamide REF: 3D-FA100622CAS: 154540-49-5 | Min. 95% | - - - | Discontinued product |
Benzamide,4-amino-5-chloro-N-[1-[(4-fluorophenyl)methyl]-4-piperidinyl]-2-methoxy-
CAS:154540-49-5
Formula:
C20H23ClFN3O2
Purity:
98%
Molecular weight:
391.8669
Ref: IN-DA007G2J
10mg | 153.00 € | ||
50mg | 595.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
Fluoroclebopride
CAS:154540-49-5
Fluoroclebopride is a dopamine (DA) D2 receptor ligand.
Formula:
C20H23ClFN3O2
Purity:
99.8% - 99.91%
Color and Shape:
Solid
Molecular weight:
391.87
Ref: TM-T3187
1mg | 35.00 € | ||
5mg | 74.00 € | ||
10mg | 95.00 € | ||
25mg | 158.00 € | ||
50mg | 232.00 € | ||
100mg | 372.00 € | ||
500mg | 846.00 € | ||
1mL*10mM (DMSO) | 95.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
4-Amino-5-Chloro-N-[1-[(4-Fluorophenyl)Methyl]Piperidin-4-Yl]-2-Methoxybenzamide
CAS:154540-49-5
4-Amino-5-chloro-N-[1-[(4-fluorophenyl)methyl]piperidin-4-yl]-2-methoxybenzamide (CLB) is a potent inhibitor of the uptake of dopamine and norepinephrine in the …
Formula:
C20H23ClFN3O2
Purity:
Min. 95%
Molecular weight:
391.87 g/mol
Ref: 3D-FA100622
5mg | Discontinued | Request information | |
10mg | Discontinued | Request information | |
25mg | Discontinued | Request information |